Sunday, December 21, 2025
ADVT 
International

No charges laid against driver of crash that left 5 Australian-Indians dead

Darpan News Desk IANS, 10 Nov, 2023 01:12 PM
  • No charges laid against driver of crash that left 5 Australian-Indians dead

Melbourne, Nov 10 (IANS) No charges have been laid as yet against an elderly driver involved in a car crash in Australia that left five Indian-origin people, including two children, dead and five others injured, police said.

The 66-year-old driver, an 'insulin-dependent diabetic' who has remained in medical care following the collision on November 5, was interrogated by the police on Tuesday.

“At this time the driver has not been charged, with enquiries to continue after his eventual release from care,” Victoria Police said in a statement.

Martin Amad, the driver's lawyer, said his client was a family man with no criminal history, and had returned a negative blood alcohol reading after the collision.

"He is deeply distressed and feels great empathy with the families and friends of the victims and the Daylesford community,” Amad said in a statement, adding that his client is an insulin-dependent diabetic who required immediate treatment from paramedics at the scene.

Vivek Bhatia (38), his son Vihan (11), Pratibha Sharma (44), her daughter, Anvi (nine), and partner Jatin Chugh (30) died after an SUV mounted a kerb and hit patrons on the front lawn of the Royal Daylesford hotel on Sunday evening.

Five other people, including Bhatia's wife, Ruchi (36), younger son Abeer (six) and an 11-month-old child, are in hospital being treated for injuries.

While addressing a news conference a day after the incident, Victoria Police Chief Commissioner Shane Patton said the victims were all visitors to the area, and described the incident as "an absolute tragedy".

Meanwhile, a candlelight vigil was organised by the Wyndham City Council where community members, including many Indians, gathered to pay tributes to the departed souls and support their families.

MORE International ARTICLES

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

China permits Indian students to return on 'need-assessed' basis

China permits Indian students to return on 'need-assessed' basis
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.

China permits Indian students to return on 'need-assessed' basis